Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study on Behalf of the Dutch Childhood Oncology Group and the German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia

Journal of Clinical Oncology

Volumn 26, Issue 27, 2008, Pages 4376-4384

  Bhojwani, Deepa ^b   Kang, Huining ^b   Menezes, Renee X ^b   Yang, Wenjian ^b   Sather, Harland ^b   Moskowitz, Naomi P ^b   Min, Dong Joon ^b   Potter, Jeffrey W ^b   Harvey, Richard ^b   Hunger, Stephen P ^b   Seibel, Nita ^b   Raetz, Elizabeth A ^b   Pieters, Rob ^b   Horstmann, Martin A ^b   Relling, Mary V ^b   Den Boer, Monique L ^b   Willman, Cheryl L ^b   Carroll, William L ^a  

^a NEW YORK UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CYTOGENETICS; FEMALE; GENE EXPRESSION PROFILING; GENE PROBE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT FAILURE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; INFANT; MALE; MODELS, STATISTICAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; ROC CURVE; TREATMENT OUTCOME;

EID: 52449106497     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.4519     Document Type: Article

References (26)

1. Pui CH, Evans WE: Treatment of acute lymphoblastic leukemia. N Engl J Med 354:166-178, 2006
2. Schultz KR, Pullen DJ, Sather HN, et al: Risk and response-based classification of childhood B-precursor acute lymphoblastic leukemia: A combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood 109:926-935, 2007
3. Gaynon PS: Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol 131:579-587, 2005
4. Alizadeh AA, Eisen MB, Davis RE, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511, 2000
5. Hayes DN, Monti S, Parmigiani G, et al: Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. J Clin Oncol 24:5079-5090, 2006
6. Golub TR, Slonim DK, Tamayo P, et al: Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286:531-537, 1999
7. Yeoh EJ, Ross ME, Shurtleff SA, et al: Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1:133-143, 2002
8. Siebel NL, Steinherz PG, Sather HN, et al: Early postinduction intensification therapy improves surivival for children and adolescents with high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group. Blood 111:2548-2555, 2008
9. Helman P, Veroff R, Atlas SR, et al: A Bayesian network classification methodology for gene expression data. J Comput Biol 11:581-615, 2004
10. Tibshirani R, Hastie T, Narasimhan B, et al: Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 99:6567-6572, 2002
11. Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc B 57:289-300, 1995
12. Hosmer D, Lemeshow S: Applied Logistic Regression (ed 2). Hoboken, NJ, John Wiley and Sons Inc, 2000
13. Martin SB, Mosquera-Caro MP, Potter JW, et al: Gene expression overlap affects karyotype prediction in pediatric acute lymphoblastic leukemia. Leukemia 21:1341-1344, 2007
14. Holleman A, Cheok MH, den Boer ML, et al: Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 351:533-542, 2004
15. Kamps WA, Bokkerink JP, Hakvoort-Cammel FG, et al: BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: Results of DCLSG protocol ALL-8 (1991-1996). Leukemia 16:1099-1111, 2002
16. Ashburner M, Ball CA, Blake JA, et al: Gene ontology: Tool for the unification of biology - The Gene Ontology Consortium. Nature Genetics 25:25-29, 2000
17. Newman JC, Weiner AM: L2L: A simple tool for discovering the hidden significance in microarray expression data. Genome Biol 6:R81, 2005
18. Nachman JB, Sather HN, Sensel MG, et al: Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med 338:1663-1671, 1998
19. Flotho C, Coustan-Smith E, Pei D, et al: A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood 110:1271-1277, 2007
20. Flotho C, Coustan-Smith E, Pei D, et al: Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: Prognostic significance of CASP8AP2. Blood 108:1050-1057, 2006
21. Brisco MJ, Sykes PJ, Dolman G, et al: Early resistance to therapy during induction in childhood acute lymphoblastic leukemia. Cancer Res 60:5092-5096, 2000
22. Borowitz MJ, Pullen DJ, Shuster JJ, et al: Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: Relation to other risk factors - A Children's Oncology Group study. Leukemia 17:1566-1572, 2003
23. Holleman A, den Boer ML, Cheok MH, et al: Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols. Blood 108:1984-1990, 2006
24. Lugthart S, Cheok MH, den Boer ML, et al: Identification of genes associated with chemotherapy cross resistance and treatment response in childhood acute lymphoblastic leukemia. Cancer Cell 7:375-386, 2005
25. Fan C, Oh DS, Wessels L, et al: Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355:560-569, 2006
26. Staal FJ, Cario G, Cazzaniga G, et al: Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks. Leukemia 20:1385-1392, 2006